- Home
- BANR vs SRPT Comparison
BANR vs SRPT Comparison
Compare BANR & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANR | SRPT |
|---|---|---|
| Founded | 1890 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.4B |
| IPO Year | 1995 | 1997 |
Fundamental Metrics
Financial Performance| Metric | BANR | SRPT |
|---|---|---|
| Price | $64.16 | $17.75 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 28 |
| Target Price | ★ $71.20 | $25.76 |
| AVG Volume (30 Days) | 290.3K | ★ 2.8M |
| Earning Date | 01-21-2026 | 02-25-2026 |
| Dividend Yield | ★ 3.13% | N/A |
| EPS Growth | ★ 15.57 | N/A |
| EPS | ★ 5.64 | N/A |
| Revenue | $647,688,000.00 | ★ $2,413,715,000.00 |
| Revenue This Year | $1.64 | $14.67 |
| Revenue Next Year | $5.86 | N/A |
| P/E Ratio | $11.32 | ★ N/A |
| Revenue Growth | 7.76 | ★ 47.15 |
| 52 Week Low | $54.01 | $10.42 |
| 52 Week High | $70.06 | $111.21 |
Technical Indicators
Market Signals| Indicator | BANR | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 49.41 | 37.66 |
| Support Level | $62.96 | $17.24 |
| Resistance Level | $66.83 | $18.69 |
| Average True Range (ATR) | 1.63 | 1.11 |
| MACD | 0.15 | -0.30 |
| Stochastic Oscillator | 50.32 | 14.90 |
Price Performance
Historical ComparisonAbout BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.